89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding 89bio, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 145 | 2 | 144 | +1 |
| Shares | 103.4M | 7.02M | 104.5M | +8.12M (+8.4%) |
| Value | $828.4M | $56.2M | $773.8M | +$1.65M (+0.2%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held 89bio, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 7,549,302 | $55.9M | 0.00% |
| Exome Asset Management LLC | 300,600 | $2.22M | 1.50% |
| PDT Partners, LLC | 169,245 | $1.25M | 0.11% |
| Prelude Capital Management, LLC | 95,500 | $706.7K | 0.05% |
| Voloridge Investment Management, LLC | 80,904 | $598.7K | 0.00% |
| HighVista Strategies LLC | 66,787 | $494.2K | 0.17% |
| CWM Advisors, LLC | 56,112 | $415.2K | 0.04% |
| Woodline Partners LP | 53,347 | $394.8K | 0.00% |
| Tudor Investment Corp Et Al | 46,617 | $345.0K | 0.00% |
| Dark Forest Capital Management LP | 23,063 | $170.7K | 0.02% |
| Intech Investment Management LLC | 21,566 | $159.6K | 0.00% |
| Ameriprise Financial Inc | 13,589 | $100.6K | 0.00% |
| Letko, Brosseau & Associates Inc | 10,700 | $79.2K | 0.00% |
| Sterling Capital Management LLC | 291 | $2.15K | 0.00% |
| Bessemer Group Inc | 130 | $1.00K | 0.00% |
| Aster Capital Management (DIFC) Ltd | 112 | $829 | 0.00% |
| National Bank of Canada | 100 | $740 | 0.00% |
Sold out (16)
Institutions that held 89bio, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Braidwell LP | 164,227 | $1.32M |
| Jump Financial, LLC | 98,597 | $789.8K |
| HRT Financial LP | 59,202 | $474.0K |
| Pennant Investors, LP | 44,500 | $356.4K |
| Balyasny Asset Management LLC | 40,656 | $325.7K |
| Schonfeld Strategic Advisors LLC | 40,488 | $324.3K |
| XTX Topco Ltd | 31,978 | $256.1K |
| Eagle Asset Management Inc | 28,658 | $222.4K |
| Fox Run Management, L.L.C. | 27,604 | $221.1K |
| Bellevue Group AG | 24,700 | $197.8K |
| Y-Intercept (Hong Kong) Ltd | 24,088 | $192.9K |
| Verition Fund Management LLC | 20,788 | $166.5K |
| Principal Financial Group Inc | 11,374 | $91.1K |
| Wetzel Investment Advisors, Inc. | 5,000 | $58.2K |
| Pacer Advisors, Inc. | 816 | $6.54K |
| Quarry LP | 139 | $1.11K |
Not filed for Q3 2024 yet (2)
Institutions that held 89bio, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 7,015,575 | $56.2M |
| Institutional & Family Asset Management, LLC | 24 | $192 |